Hims Hers $1.2 Billion Global Leap Draws Investor Scrutiny
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articlesHims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Webull’s March-quarter results reveal a bold pivot: the CEO says B2B revenue could rival or surpass retail in the com...
Georgia lawmakers have postponed plans to remove barcode voting from ballots, keeping QR-code systems in use and dela...
The Mortgage Bankers Association reports mortgage demand rises 1.7% in the latest weekly survey, with purchases up an...
A surge in quantum-tech optimism helped lift IonQ shares even without direct news from the company. Here’s what happe...
A 65-year-old widow faces a pivotal decision: switch to her own Social Security benefit now or wait, risking a smalle...
Retirees are increasingly building a dividend-driven portfolio that funds two annual cruises while keeping principal ...
Tech insiders are stepping up their open-market purchases in software, chipmakers, and AI platforms, reviving a contr...
Amazon is quietly expanding its in-house silicon beyond data center basics, pushing Graviton and Trainium into broade...
As the 10-year Treasury sits in the low- to mid-4% zone, select dividend stocks more than keep pace with bond returns...
Carvana stock has faced a rough start to 2026, with the headline move being a sizable drop. This guide breaks down wh...
This deep-dive breaks down veru (veru) 2026 earnings, translating the quarterly numbers into a clear sense of cash he...